Home
Search

Press Releases

Get the latest on BIO's announcements, positions and views on everything from healthcare to biofuels. 

Featured Press Releases
BIO Statement Regarding Nomination of Robert F…
BIO President & CEO John F. Crowley released the following statement:“A healthy and prosperous society is vitally important to the American people and to the world. The public health, economic security and our national security are best served…
Learn more
BIO Released the Following Statement After…
“The Biotechnology Innovation Organization (BIO) applauds today's announcement from the USDA's Animal and Plant Health Inspection Service (APHIS) expanding the scope of biotechnology exemptions for modified plants under 7 CFR part 340. This…
Learn more
BIO Statement on Lawsuit Over 340B Rebates
BIO strongly supports a manufacturer’s ability to use a 340B rebate as an appropriate option to make 340B pricing available to covered entities."Manufacturers should have the choice to effectuate 340B pricing in the manner they deem most efficient…
Learn more
All Press Releases
  • Show All
Search
Results
Event Tags
Now is the Time to Seize Bioeconomy Opportunities in Farm Bill
July 26, 2023
The next farm bill offers opportunities to invest in long-term food security, climate resiliency and growing the nation’s burgeoning bioeconomy, according to the Biotechnology Innovation Organization, which has submitted recommendations to the House…
PAHPA committee votes "important step forward" in public health preparedness
July 20, 2023
Two Congressional committees this week pushed through legislation to reauthorize the Pandemic All Hazards and Preparedness Act (PAHPA). Following the votes, Phyllis Arthur -- Senior Vice President, Infectious Diseases & Emerging Science…
Reasonable Pricing Clause in PAHPA Undermines Ability To Protect Country And Prepare for Future Pandemics
July 3, 2023
The Senate HELP Committee today released a discussion draft of legislation to reauthorize the Pandemic and All-Hazards Preparedness Act (PAHPA). BIO represents many small- and mid-size companies that are at the heart of the type of public-private…
New CMS guidance a "missed opportunity" for future medical innovation, patients
June 30, 2023
The Centers for Medicare & Medicaid Services (CMS) today released its guidance for the Drug Price Negotiation Program (Negotiation Program) under the Inflation Reduction Act of 2022 (IRA). John Murphy, BIO’s Chief Policy Officer, made the…
BIO: Delay of R&D Tax Burden is Positive Step, Permanent Repeal Still Needed
June 15, 2023
The House Ways & Means Committee has approved a bill that includes language to delay retroactively through 2025 the mandatory capitalization of research and development expenses, which took effect in tax year 2022. The Tax Cuts and Jobs Act of…
The Coalition of State Bioscience Institutes (CSBI) Releases the 2023 Life Sciences Workforce Trends Report at BIO International Convention
June 7, 2023
"The intense competition for talent in 2021, 2022 and into early 2023 extended to the life sciences as the nation’s overall unemployment rate reached                            …
Massachusetts Speaker of the House Ron Mariano Honored as BIO Legislative Champion
June 6, 2023
Today, the Biotechnology Innovation Organization (BIO) presented Speaker of the Massachusetts House of Representatives Ronald J. Mariano with BIO’s Legislative Champion Award. Speaker Mariano received the award in conjunction with the BIO…
New Report Explores Latest Best Practices in State Bioscience Economic Development Initiatives
June 6, 2023
Today, the Biotechnology Innovation Organization (BIO), in partnership with the Council of State Bioscience Associations (CSBA), released a new report on the best practices in state bioscience economic development measures, “The U.S. Biosciences…
BIO Elects Dr. Ted W. Love as New Board Chair
June 5, 2023
2023-2024 BIO Executive Committee is Accomplished, Energetic and Diverse Boston, Mass. (June 5, 2023) – Biotechnology Innovation Organization (BIO) is proud to announce its newly elected Executive Committee Directors following Board elections that…
BIO Applauds USTR for Taking Next Step to Return Mexico to Science-Based Policy
June 2, 2023
The following statement may be attributed to Nancy Travis, vice president for international affairs, BIO. “The Biotechnology Innovation Organization supports the decision, announced today, by the Office of the U.S. Trade Representative to request…
gooddaybio-cover-final
Daily News You Can’t Afford to Miss

Read it in under 3 minutes!

The Good Day BIO newsletter is the only daily newsletter at the intersection of biotech, politics, and policy. 

Sign Up Today